miR ‐1301‐3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression

ConclusionMiR-1301-3p is a potential biomarker for predicting the prognosis of ESCA patients. It may promote ESCA invasion, migration and EMT progression by regulating NBL1 expression.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research